Evidence map›Paper›PMID 42287471›Full record

ArticleEJNMMI radiopharmacy and chemistry2026

Development and evaluation of improved in-house procedure for radiolabelling of theranostic agent [

Nino Jukić, Dražen Huić, Marijan Žuvić, Ivan Nemet, Sanda Rončević

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nino JukićDepartment of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia.
Dražen HuićDepartment of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia.
Marijan ŽuvićDepartment of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia.
Ivan NemetDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, Zagreb, Croatia.
Sanda RončevićDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, Zagreb, Croatia. roncevic@chem.pmf.hr.ORCID http://orcid.org/0000-0002-1899-6382

Funding

European Regional Development Fund KK.01.1.1.02.0016International Atomic Energy Agency E13048Prognostic Value of Arterial 18F-FDG PET Imaging - The PIAF Trial
6 · The paper itself

Abstract

backgroundRecent focus in the treatment of prostate cancer is directed towards the development and application of theranostic agents such as [

resultsThe radiopharmaceutical was obtained with > 95% radiochemical purity and > 96% radiochemical yield. The addition of ethanol improved radiochemical yield. The obtained product maintained > 98% radiochemical purity for up to 72 h in isotonic saline and human serum at 25 °C and 37 °C. The use of carrier-added

conclusionComparative quality control demonstrated generally equivalent quality attributes of in-house prepared product and the reference product, supporting in-house product suitability for routine clinical application at activities up to 7.4 GBq. This experiment showed that in-house production of

Indexed as

[177Lu]Lu-PSMA-617HPLC analysisICP-MS analysisQuality controlRadiopharmaceutical labellingTLC analysis

Identifiers

PMID42287471
PMCPMC13493687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.